Company ProfilePremium

Buka Investments Limited

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Buka Investments Limited - Company showcase

Year Founded & Workforce

2020

Buka Investments Limited logo

Buka Investments Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Buka Investments Limited Overview

Buka Investments Limited is a dormant former listed shell. For about fifteen years it was the listed parent of a South African beauty and wellness franchisor whose brands were Placecol Skin Care Clinics, Dream Nails Beauty Salons and Perfect 10 Nail and Body Studios. It also owned the Placecol skin care product range.

The operating group lost revenue for years, falling from R101.1m in FY2016 to R19.0m by FY2022. COVID-19 then forced a restructuring. An Absa Bank COVID-19 loan required the operating subsidiary to sit outside a JSE-listed group, so management sold every subsidiary to the related-party i-BLOOM group for R7.63m. A new controlling shareholder, B&B Media, took 61.26% of the empty listed vehicle.

B&B Media renamed the company Buka Investments and planned a reverse takeover into fashion footwear (Socrati Footwear and Caralli Leather Works). That deal was shelved in February 2023. The JSE suspended the shell and later removed its listing on 4 September 2024. Today Buka is an unlisted company with negligible net assets and no disclosed operations.


The company's own description (paraphrased from its latest operating-era filings)

In its FY2020 results (year ended 29 February 2020), Imbalie Beauty described itself as a beauty and wellness solutions group. It said its primary focus was developing, growing and innovating its own skin care product brands and treatments, delivered through a franchise salon footprint of three chains: Placecol Skin Care Clinics, Perfect 10 and Dream Nails Beauty Salons. It said its skin care brands reached consumers through its own salon footprint, large retail groups, pharmacies, independent salons and online platforms. (Source: Imbalie Beauty reviewed provisional results FY2020, 7 Aug 2020.)

After the disposal, Buka's FY2023 audited results (31 May 2023) describe the company as a listed shell on the JSE. They say it intended to acquire "earmarked fashion businesses", subject to board, shareholder and JSE approval. Profile ShareData's company summary describes Buka's intended model as a house of brands: retailers of exclusive shoes and accessories sourced internationally and locally, with the Socrati and Caralli acquisitions pending. Those acquisitions never completed.

Independent characterisation

Phase 1: operating beauty franchisor (2007 – January 2022). The business model was a hybrid of three things:

  1. A franchisor, earning royalties and fees from franchised salons. The group had more than 150 salons nationally in FY2016 and January 2018.

  2. A brand owner and distributor of its own skin care brands (Placecol, Skinderm) and of third-party professional brands. Products were sold into the salon network, retailers (including in-store beauty outlets in Edcon stores) and pharmacies.

  3. A training provider through the Imbalie Beauty Training Academy, later the Imbalie Beauty Wellness Academy and the i-BLOOM Beauty & Wellness Academy.

The group also owned corporate salons until FY2017, when it decided to close them. Until 2020 it held head leases on behalf of franchisees, which created contingent liabilities.

Phase 2: cash shell (February 2022 – September 2024). From February 2022 the listed company held only cash, receivables and a deferred tax asset. It had no revenue. Its expenses were mainly JSE, sponsor, audit, legal and directors' fees.

Phase 3: unlisted dormant entity (September 2024 – present). No public information was found on its activities, assets or any later transaction.

Revenue model mix (operating era)

Revenue streamDescriptionDisclosed split
Product sales (own brands)Placecol and Skinderm skin care sold to salons, retailers and pharmacies—
Product sales (third-party brands)Imported international professional brandsNot publicly disclosed. Management said it deliberately shifted toward own brands in FY2020–FY2022 to lift gross margin
Franchise royalties and feesRoyalties from franchised salonsNot publicly disclosed. Royalties received from the related-party Beauty Flagship salons were R1.197m (FY2019), R540k (FY2020) and R1.21m (FY2022)
TrainingAcademy courses (34 courses offered in FY2017)—
Rental incomeProperty (Imbalie Innovation) let to related parties such as Amka ProductsR90k (FY2020), R152k (FY2021), R114k (FY2022) to Amka Products

The group never reported by segment. It stated that it was managed as one operating unit (IFRS 8 disclosure, FY2020–FY2023).

Value chain position, customers and end-markets

Value chain: A brand owner and franchisor in the middle of the professional beauty value chain. Manufacturing appears to have been outsourced (the FY2020 results reference brand development but no factories). Distribution was outsourced in FY2017 (BusinessDay, 2 Jun 2017).

Customer types: Franchisees, independent salons, large retail groups such as Edcon, pharmacy groups (a pharmacy group ordered Placecol for 93 new outlets on 26 March 2020), and end consumers through online channels and the Customer Solutions Division launched 3 August 2020.

End-markets: Professional salon treatments and retail skin care in South Africa, with some cross-border sales in Southern Africa (BusinessDay, 31 Jan 2018; FY2020 IFRS 8 note).

Strategy

Stated strategy, by era (paraphrased)

EraStated strategic themesSource
FY2017–FY2020 (Imbalie)Turnaround: close corporate salons, outsource distribution, build a training academy, focus on own brands for margin, grow pharmacy and retail distribution, open "more successful" franchised salons. The vision was to be the leading and most desirable beauty and wellness solutions group nationally and internationallyBusinessDay 2 Jun 2017; FY2020 results
FY2021 (COVID)Survival and repositioning: Customer Solutions Division, digitising the academy, R7m rights offer (not implemented), sale of the property company to settle debtFY2020 results
FY2022 (disposal)Comply with the Absa loan condition by moving operations into an unlisted entity (i-BLOOM), citing substantial cost savings outside the JSEFY2022 results; Business Report 7 Jul 2021
FY2023 onward (Buka)Reposition and rebrand into the fashion industry by reversing "earmarked fashion businesses" into the listed shell, with the stated aim of creating substantial shareholder value. The board said it was confident the major shareholder's business acumen combined with the listing would build a sizable listed fashion businessFY2022 results; FY2023 results; interim Aug 2023

Initiative register (last 24 months of public disclosure: Sep 2022 – Sep 2024)

InitiativeDateStatusSource
Socrati Footwear / Caralli Leather Works reverse takeover (share-for-share, treated as a new listing)Heads of Agreement 14–15 Jul 2022JSE extension to 31 Dec 2022 for the circular. Put on hold 24 Feb 2023Interim Aug 2022; FY2023 results
Revised reverse-takeover strategy "in conjunction with advisors"Announced 29 Sep 2023, with a final transaction expected within about four monthsNever announced. Listing removed 4 Sep 2024Interim Aug 2023
Cost programmesNone disclosed. Costs rose 178% in FY2023 because of audit, legal, JSE and directors' fees—FY2023 results
ESG / sustainability commitmentsNone disclosed for Buka. Profile ShareData's summary describes the target fashion house as built around sustainability and community upliftment—Profile ShareData

Medium-term targets and guidance

None were ever published. The only forward-looking quantitative statement is the FY2024 trading statement (loss per share of 17.00–20.00c).

Products & Services

All of the portfolio below belonged to the pre-2022 operating group and now sits outside Buka. Buka itself has no products or services.

Franchise salon chains

BrandDescriptionTarget customerYear / statusPricing modelSource
Placecol Skin Care ClinicsFranchised skin care clinics offering facial and body treatments built around Placecol products. Repeatedly recognised by "Best of Bloemfontein", including a fifth consecutive year in 2019Mid-market female consumers who want professional skin carePart of the original Placecol business; now i-BLOOMFranchise royalties and fees (rates not disclosed)FY2020 results; interim Aug 2019
Dream Nails Beauty SalonsFranchised nail and beauty salonsMass-market nail and beauty consumersAcquired 2007 at listing; now i-BLOOMFranchise royalties (not disclosed)FY2022 results
Perfect 10 Nail and Body StudiosFranchised nail and body studiosMass-market nail and beauty consumersAcquired from A&V Beauty Products, effective 1 Mar 2012; now i-BLOOMFranchise royalties (not disclosed)Skinwell SENS 6 Mar 2012
i-BLOOM by Placecol Skin, Hair & BeautyNew salon format. The first store opened at Chartwell Corner, Fourways, in Jan 2022Premium all-in-one beauty consumerLaunched Jan 2022, at the time of the disposal; never part of Buka—Team France Export / Professional Beauty
Corporate (company-owned) salonsGroup-operated salons—Closure decided in FY2017 with a R9.9m impairment—BusinessDay, 2 Jun 2017

Footprint: more than 150 salons nationally in FY2016 and January 2018 (SENS 31 May 2016; BusinessDay 31 Jan 2018). FY2020 refers to closures of unprofitable salons. Group head leases held for franchisees fell from 28 in 2019 to 7 by July 2020 (FY2020 results).

Own skin care brands

Brand / rangeDescriptionChannelsLaunch / latestSource
Placecol (core range)South African professional and retail skin care brand, about 40 years old in 2020. Its trademarks were revalued in FY2020, reversing an earlier impairment of R1.46mSalons, retail groups, pharmacies, onlinec.1980; trademark carrying value restored in FY2020FY2020 results; Profile Stock Exchange Handbook 2021
Placecol ExcellenceRange positioned around skin care at a biological level. Won a Pharmaceutical and Cosmetic Review award in Oct 2019Salons, pharmaciesLaunched Jun 2019FY2020 results
SkindermOwn skin care brand named in company descriptionsSalons, retailLaunch year not disclosedGuruFocus business description (aggregator)
BrandRoleSource
Beauté PacifiqueImported professional skin care distributed by the groupSimply Wall St / Yahoo Finance profile
BioeffectImported skin care distributed by the groupSimply Wall St / Yahoo Finance profile
BodyographyCosmetics distributed by the group (spelled "Bodyograpgy" in the aggregator text)Simply Wall St / Yahoo Finance profile
"Scinderm"Appears in aggregator text and may be a duplicate or misspelling of SkindermSimply Wall St / Yahoo Finance profile

Services and other offerings

OfferingDescriptionLaunchSource
Imbalie Beauty Training Academy / Wellness AcademyBeauty and wellness training. Offered 34 courses at launch in FY2017; trained the salon network in COVID protocols in 2020FY2017BusinessDay, 2 Jun 2017; FY2020 results
i-BLOOM Beauty & Wellness AcademyOnline international training and education platform for beauty professionalsOct 2020Team France Export; Ghost Mail
Customer Solutions DivisionDirect-to-consumer sales of salon-quality home-use products, plus training therapists for home-based services3 Aug 2020FY2020 results; Ghost Mail
i-BLOOM magazineConsumer magazine about skin, hair and beauty solutionsSep 2020Team France Export
Edcon in-store beauty outletsBeauty stores inside some Edcon outletsAgreement announced Jan 2018BusinessDay, 31 Jan 2018

Planned (never completed) Buka portfolio

TargetDescriptionStatusSource
Socrati Footwear (Pty) LtdEstablished South African retailer of women's and men's shoesHeads of Agreement 14–15 Jul 2022. Put on hold 24 Feb 2023. Never completedInterim Aug 2022; FY2023 results; Profile ShareData
Caralli Leather Works (Pty) LtdMen's leather shoe manufacturerAs aboveAs above
Eddels Shoes (Pty) LtdShoe manufacturer in Pietermaritzburg, acquired by B&B Media (not Buka) in Feb 2023Not a Buka assetFY2023 results

Financial Narrative

Basis of preparation and comparability warnings

  1. Five audited years used: FY2019 to FY2023. FY2024 (year ended 29 Feb 2024) audited results were due in the first week of July 2024, according to the 27 Jun 2024 trading statement. They could not be retrieved; the JSE PDF repository blocked access. Only the trading-statement range is available.

  2. FY2021 and FY2022 operating figures come from the discontinued-operations note in the FY2022 audited results.

  3. All per-share figures are restated for the 1:100 consolidation of 6 July 2022. For FY2019–FY2021 the restatement is the reported cents × 100. For FY2022 and FY2023 the figures are the post-consolidation amounts as reported.

  4. FY2022 includes a R22.428m IAS 27 loss on disposal of subsidiaries.

  5. FY2022 operating revenue covers 11 months.

Income statement

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Per-Share Data

MetricFY2019FY2020FY2021FY2022FY2023

Revenue incl. discontinued operations (ZAR K)

41,80933,57819,04619,0040

Cost of sales (ZAR K)

16,09810,1835,4595,4010

Gross profit (ZAR K)

25,71123,39513,58713,6030

Other operating income (ZAR K)

2,8222,5272,1031,1480

Total operating expenses incl. listing costs (ZAR K)

29,92124,04319,59015,3533,124

Goodwill impairment (ZAR K)

003,56000

EBIT excl. disposal loss (ZAR K)

-2,671377-7,460-602-3,124

Finance costs (ZAR K)

2,3971,9351,4331,2380

Investment income (ZAR K)

1176250194

Loss on disposal of subsidiaries (ZAR K)

00022,4280

Pre-tax profit/(loss) (ZAR K)

-4,951-1,496-8,888-24,268-2,930

Taxation credit/(charge) (ZAR K)

1,655-674-483906-947

Net loss attributable (ZAR K)

-3,296-2,170-9,371-23,362-3,877

Headline loss (ZAR K)

-3,295-3,728-5,869-1,022-3,877

Basic EPS consolidation-adjusted (ZAR cents)

-24-16-68-168.79-28.01

Headline EPS consolidation-adjusted (ZAR cents)

-24-27-42-7.39-28.01

Diluted EPS consolidation-adjusted (ZAR cents)

-24-16-68-168.79-28.01

Dividends per share (ZAR cents)

00000

Weighted average shares post-consolidation (million)

13.7713.8413.8413.8413.84

Margin Analysis (%)

MetricFY2019FY2020FY2021FY2022

Gross margin (%)

61.5069.6771.3471.58

EBIT margin excl. disposal loss (%)

-6.391.12-39.17-3.17

Net margin (%)

-7.88-6.46-49.20-122.93

Operating expenses to revenue (%)

71.5771.60102.8680.79

Income Statement

MetricFY2015FY2016FY2017FY2019FY2020FY2021FY2022FY2023

Revenue (ZAR K)

91,886101,11196,50041,80933,57819,04619,0040

Income Statement (Half-Yearly)

MetricH1 FY2019H1 FY2020H1 FY2021

Six-month revenue to 31 Aug (ZAR K)

22,41018,3757,646

Six-month loss before tax (ZAR K)

-2,550-384-3,690

Balance Sheet and Per-Share Data

MetricFY2019FY2020FY2021FY2022FY2023

Total assets (ZAR K)

72,20467,31961,2077,0793,521

Cash and equivalents gross (ZAR K)

1314710713,273

Bank overdraft (ZAR K)

3,9374,0212,07100

Total interest-bearing debt incl. overdraft and leases (ZAR K)

19,32718,93223,41700

Net debt (ZAR K)

19,19618,88523,310-1-3,273

Goodwill and intangible assets (ZAR K)

17,46519,22915,32300

Deferred tax asset (ZAR K)

23,98522,97522,5369470

Total liabilities (ZAR K)

30,30928,03231,291524844

Total equity (ZAR K)

41,89539,28729,9166,5542,677

Accumulated loss (ZAR K)

-72,871-75,041-84,412-107,179-111,055

Stated capital (ZAR K)

113,732113,732113,732113,732113,732

NAV per share consolidation-adjusted (ZAR cents)

30328421647.3519.34

Key Financials

MetricFY2019FY2020

Short-term debt incl. overdraft and leases (ZAR K)

11,5204,672

Long-term debt (ZAR K)

7,807143

Debt reclassified to disposal groups (ZAR K)

014,117

Liquidity & Coverage Ratios

MetricFY2019FY2020FY2022FY2023

Working capital (ZAR K)

-7,888-3,9165,6072,677

Cash Flow

MetricFY2019FY2020FY2021FY2022FY2023

Operating cash flow (ZAR K)

2531,121-3,108-5183,272

Net investing cash flow (ZAR K)

27734831,6410

Net financing cash flow (ZAR K)

-124-1,3624,6358420

Net change in cash (ZAR K)

156-1682,0101,9653,272

Closing cash net of overdraft (ZAR K)

-3,806-3,974-1,96413,273

Dividends paid (ZAR K)

00000

Share buybacks (ZAR K)

00000

Proceeds from share issues (ZAR K)

3,3160000

Cash Flow (FY2019–FY2020)

MetricFY2019FY2020

Capex incl. PPE and intangibles (ZAR K)

27638

Free cash flow (OCF less capex) (ZAR K)

226483

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2019FY2020FY2021FY2022FY2023

ROE on closing equity (%)

-7.87-5.52-31.32-356.45-144.83

ROA on closing assets (%)

-4.56-3.22-15.31-330.02-110.11

Debt to equity (x)

0.460.480.7800

Asset turnover on closing assets (x)

0.580.500.312.680

Financial Ratios (x)

MetricFY2019FY2020FY2021FY2022

Interest coverage (x)

-1.110.19-5.211.28

Financial Ratios (x) (FY2019–FY2023)

MetricFY2019FY2020FY2022FY2023

Current ratio (x)

0.640.7211.704.17

Working Capital (Days)

MetricFY2019FY2020

Days inventory outstanding (days)

133.8197.5

Days sales outstanding (days)

64.546.0

Days payables outstanding (days)

232.7326.2

Cash conversion cycle (days)

-34.4-82.7

Revenue by Region and Revenue by Region (%)

MetricFY2020FY2021FY2022

South Africa incl. cross-border sales by SA companies (ZAR K)

33,57819,04619,004

South Africa share of revenue (%)

100100100

South Africa revenue growth YoY (%)

-19.7-43.3-0.2

Valuation Snapshot

MetricValueAs ofSource

Last price (approx.)

R0.73

Suspended price, carried to removal

GuruFocus; implied by Profile ShareData market cap

Market capitalisation

R10.10m

3 Sep 2024

Profile ShareData

Shares in issue

13,840,392

Since 6 Jul 2022

FY2023 results

1-year total return (CAGR)

0.00% (no trading while suspended)

17 Dec 2024

iocharts (aggregator)

3-year return (CAGR)

-96.68%

17 Dec 2024

iocharts (aggregator)

5-year return (CAGR)

-87.04%

17 Dec 2024

iocharts (aggregator)

10-year return (CAGR)

-69.83%

17 Dec 2024

iocharts (aggregator)

Market Valuation

MetricAug 2022Aug 2023Sep 2024

Market capitalisation (ZAR Mn)

13.410.110.1

Valuation Multiples

MultipleBukaComment

P/B vs FY2023 equity (R2.677m)

3.8x

R10.1m ÷ R2.677m

P/B vs Aug 2023 equity (R1.053m)

9.6x

R10.1m ÷ R1.053m

Enterprise value (Aug 2023)

About R8.7m

Market cap R10.1m less cash R1.41m; no debt

Peer multiples

Not compiled

Not meaningful for a shell

Capital Markets

ItemDetail

Dividend history

No dividends paid in any year retrieved (FY2015–FY2023). Each set of results states that no dividend will be paid

Dividend policy

Not formally articulated beyond the annual "no dividend" statements

Buyback authorisations

None disclosed

Credit ratings (Moody's, S&P, Fitch)

Not rated

Debt maturity profile

No debt since Feb 2022. Before the disposal, debt was mostly short-term: R11.5m short-term vs R7.8m long-term in FY2019

Capital raisings

Three rights offers since the 2007 listing, the last in Jan 2018 (R3.3m raised against a R15m target). About R6m injected in connection with the 2022 control change

Analyst consensus

None. No sell-side coverage identified

Corporate actions

1:100 consolidation on 6 Jul 2022. Authorised capital raised to 2bn shares. ISIN changed from ZAE000165239 to ZAE000309118

Analyst Conclusions

Management guidance and consensus

Last management guidance: the FY2024 trading statement (27 Jun 2024), which guided to a loss per share of 17.00–20.00c, and the September 2023 statement that a revised reverse-takeover transaction would be announced within four months. That transaction was never announced.

Consensus growth expectations: none. There is no analyst coverage, and the company is now unlisted.

Bull case (low-probability)

  1. Re-injection of footwear assets. B&B Media owns or controls a retail-plus-manufacturing footwear chain (Socrati, Caralli, Eddels). If it chose to recapitalise Buka and inject these businesses, minorities could participate in an operating company. The AltX advisory committee's 2022 eligibility view shows the structure was once considered workable.

  2. Debt-free and cheap to maintain. The shell had no debt or contingencies at FY2023. Unlisted, it no longer has to pay JSE and sponsor fees, which were R1.2–1.5m a year in FY2022–FY2023. This removes most of the cash burn and could preserve a vehicle for future use.

  3. Tax-loss value. An accumulated loss above R111m may include assessed tax losses (not disclosed) that could have value in a restructuring, subject to tax law.

Bear case (high-probability)

  1. No operations, no listing, near-zero equity. Equity was R1.05m in Aug 2023. The guided FY2024 loss of R2.35–2.77m implies equity of roughly zero or negative by February 2024 unless capital was injected.

  2. The controlling shareholder has walked away from the transaction before. It shelved the reverse takeover in favour of its own Eddels deal, and did not contest the JSE's removal decision. Without a listing, the controlling shareholder has little incentive to inject assets into a vehicle shared with minorities.

  3. Minorities' exit route has closed. The shares cannot be traded on an exchange, there are no continuing JSE disclosure obligations, and no public filings were found from September 2024 to October 2026. Liquidity and information risk for minority holders is therefore extreme.

Catalysts and monitorables (next 12 months)

MonitorableWhy it matters
CIPC company status (active, deregistration, business rescue, liquidation)Shows whether the entity continues to exist
Any shareholder communication from Buka or B&B MediaAny recapitalisation, buy-out offer to minorities, or asset injection
Filing of FY2024 and FY2025 annual financial statements (required under the Companies Act for a public company)Confirms capital position and going concern
B&B Media / Socrati / Eddels corporate activitySignals whether footwear assets are being consolidated elsewhere
i-BLOOM group statusHistorical interest only; it holds the former Imbalie brands, but Buka has no economic interest

Concluding analyst verdict

Buka Investments Limited is best understood as the empty legal shell left after a long, value-destroying corporate history, not as an investable company. Its operating predecessor, Imbalie Beauty, owned a credible heritage brand in Placecol and achieved premium gross margins of about 70%. It never converted that into operating profit. Revenue collapsed by about 81% between FY2016 and FY2022, from R101.1m to R19.0m. In the five audited years to FY2023 the business produced only one marginally positive EBIT year. By the time the company became a shell, it had lost roughly 98% of the R113.7m of capital ever contributed.

COVID-19 sped up an outcome that the FY2020 balance sheet was already signalling: interest cover of 0.19x, net debt about 10x EBITDA, a current ratio of 0.72x and an auditor's going-concern warning. Absa's lending condition made separating the operations from the listing unavoidable. The R7.63m related-party sale to i-BLOOM crystallised a R22.4m loss and moved every brand outside the listed perimeter.

The 2022 repositioning into fashion depended entirely on one actor: the controlling shareholder, B&B Media. When B&B Media prioritised its own Eddels acquisition, the reverse takeover stalled. The shell breached the JSE's six-month cash-shell rule, was suspended on 24 February 2023, missed its own four-month target for a revised deal, and was removed from the JSE on 4 September 2024 without appealing.

The remaining equity was being consumed mostly by directors' and listing fees and was close to nil on the FY2024 guidance. Minority shareholders now hold unlisted, illiquid shares in an entity that has made no public disclosure for more than two years. Without a voluntary recapitalisation or buy-out by the controlling shareholder, which has not been signalled, the realistic expected value for minorities is close to zero.

Verdict: no fundamental value; treat as a write-off pending any shareholder communication.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleTenureBackground / notesFY2023 remuneration (ZAR K)H1 FY2024 remuneration (ZAR K)Source

Abdurrahim Bux

CEO, executive director

Director from 25 Apr 2022; CEO from 1 Aug 2022

Linked to the B&B Media consortium. Prior roles and education not disclosed in retrieved filings. Age not disclosed

280240

FY2023 results; interim Aug 2023

Werner Grobbelaar

Financial Director / CFO

From 1 Aug 2022

B.Com. Born 1971 (Yahoo Finance; Investing.com gives age 53)

10590

FY2023 results; Yahoo Finance

(Mohammed) Talib Sadik ("MT Sadik")

Independent non-executive chairman

From 25 Apr 2022

Prior roles not disclosed

220146

FY2023 results; interim Aug 2023

Paul Alexandre François Raoul Inbona

Independent non-executive director; chaired the Audit and Risk Committee

From 25 Apr 2022

Prior roles not disclosed

179119

FY2023 results

Pumla Tladi

Independent non-executive director

From 14 Dec 2022

Investing.com lists her as Independent Chairman, age 50.

30112

FY2023 results; Investing.com

Esna Colyn CA(SA)

Non-executive director (CEO until 2022); chaired the Remuneration Committee in 2022

Director since 2010 per Investing.com; CEO through FY2022

Chartered accountant who led Imbalie through the FY2017 restructuring, COVID and the disposal. Owns the salon company Beauty Flagship (Pty) Ltd (a related party). Later named CEO of i-BLOOM Solutions

110112

FY2022 and FY2023 results; Team France Export

Board of Directors — NVB Magubane

NameRoleRemuneration history (ZAR K)Exit

NVB Magubane

Non-executive director; chaired the Social and Ethics Committee

92 (FY2023)

Appointed 25 Apr 2022; passed away 30 Oct 2022

A Cassim

Financial Director

—

25 Apr 2022 – 31 Jul 2022

CW de Jager

Financial Director

478 (FY2019), 814 (FY2020), 769 (FY2021)

Left before FY2022

JH Phalane

Independent chairman

20 (FY2021), 100 (FY2022)

Resigned 25 Apr 2022

GD Harlow

Chaired the Nominations Committee

80 (FY2021, FY2022)

Resigned 25 Apr 2022

TJ Schoeman

Chaired the Audit and Risk Committee

80 (FY2021, FY2022)

Resigned 25 Apr 2022

WP van der Merwe

Chaired the Remuneration Committee

80 (FY2021, FY2022)

Resigned 25 Apr 2022

BJT Shongwe

Independent chairman (2020)

50 (FY2021)

Left by FY2022. Profile ShareData still lists him as chairman, which is stale data

“—” = not publicly disclosed.

Directors' Remuneration

MetricFY2019FY2020FY2021FY2022

CEO remuneration E Colyn (ZAR K)

9669459811,001

Directors' Remuneration (FY2023–H1 FY2024)

MetricFY2023H1 FY2024

Executive director remuneration (ZAR K)

385330

Non-executive director fees (ZAR K)

631489

Total board cost (ZAR K)

1,016819

"Other operating expenses" (ZAR K)

1,9211,487

Governance Overview

FeatureDetail

Board size (Sep 2023)

6 directors: 2 executive and 4 non-executive, of whom 3 independent (Sadik, Inbona, Tladi)

Chair/CEO separation

Yes. Independent chair (Sadik), separate CEO (Bux)

Committees (2022 disclosure)

Audit and Risk (chaired by Inbona), Social and Ethics (chaired by Magubane until her death), Remuneration (chaired by Colyn), Nominations (chaired by Harlow until his Apr 2022 resignation)

Governance code

The company stated a commitment to King IV (interim Aug 2023)

Gender

2 of 6 directors were women in Sep 2023 (Colyn, Tladi), about 33%

Major Shareholders

HolderStakeNotesSource

B&B Media (Pty) Ltd

61.26%

Acquired from previous major shareholders, effective 31 Jan 2022. Described as a fully Black-owned family business engaged mainly in advertising, with fashion and retail interests (Socrati; Eddels from Feb 2023)

FY2022 results; interim Aug 2023; Ghost Mail

Institutional ownership

Not publicly disclosed; likely negligible given the AltX micro-cap profile

——

Insider ownership

Not publicly disclosed beyond B&B Media's control stake (A Bux's link to B&B Media is implied by the board reconstitution but not quantified)

——

Shares in issue

13,840,392 ordinary no-par shares (after consolidation). Authorised: 2,000,000,000

—

FY2023 results

Competitive Landscape

Key Competitors

CompetitorSegment overlapRelative positioning vs Imbalie (qualitative)

Sorbet (salon franchise chain)

Franchised nail, beauty and skin salons

National franchise chain in direct competition for mall sites and franchisees

Candi & Co (nail bars)

Nail services

Competes with Dream Nails and Perfect 10 for mass-market nail services

Independent day spas and salons

Salon treatments

Fragmented and price-competitive; also an Imbalie distribution channel

Environ (South African-founded skin care brand)

Professional skin care

Strong professional brand competing with Placecol in clinics

Dermalogica

Professional skin care

International professional brand sold through salons

Clicks (pharmacy and beauty retail)

Retail skin care

Both a channel and a competitor through private-label and stocked brands

Dis-Chem (pharmacy retail)

Retail skin care

Both a channel and a competitor

International mass and prestige skin care brands in SA retail

Retail skin care

Large marketing budgets; compete for shelf space

Direct-selling cosmetics operators in SA

Home and direct beauty sales

Overlaps with the 2020 Customer Solutions Division model

Online beauty retailers

E-commerce

Competes with the group's online channel

Key Competitors — Mr Price Group

CompetitorOverlap

Mr Price Group

Mass footwear retail

TFG (The Foschini Group)

Fashion and footwear retail

Pepkor

Value footwear

Edcon / Edgars (post-rescue owners)

Department-store footwear

Specialist independent shoe chains

Directly comparable to Socrati

Local leather shoe manufacturers

Comparable to Caralli and Eddels

Peer Comparison FY2020

MetricImbalie Beauty (FY2020, last full pre-COVID year)Peer 1Peer 2Peer 3

Revenue

R33.6m

Not compiled

Not compiled

Not compiled

Revenue growth

-19.7%

Not compiled

Not compiled

Not compiled

Gross margin

69.7%

Not compiled

Not compiled

Not compiled

EBIT margin

1.1%

Not compiled

Not compiled

Not compiled

R&D intensity (capitalised development / revenue)

1.7%

Not compiled

Not compiled

Not compiled

Recent Developments

Disclosure gap. The research found no public disclosures by or about Buka Investments between 4 September 2024 (removal of listing) and 13 October 2026.*

Company Snapshot

2020

Founded

Parktown, South Africa

Headquarters

SWOT Analysis

Strengths

  • Heritage brand. Placecol had about 40 years of heritage in 2020, and an independent trademark valuation in FY2020 supported reversing R1.46m of earlier impairment (FY2020 results).
  • High gross margin. 69.7% in FY2020 and 71.5% in FY2022, achieved by focusing on own brands (FY2020 and FY2022 results).
  • Award-winning product development. The Placecol Excellence range (launched Jun 2019) won a Pharmaceutical and Cosmetic Review award in Oct 2019 (FY2020 results).
  • National footprint. More than 150 franchise salons nationally at its peak (SENS 31 May 2016; BusinessDay Jan 2018).
  • Clean shell balance sheet after disposal. No debt and no contingent liabilities at FY2022 and FY2023, and unmodified audit opinions in both years (FY2022 and FY2023 results).
  • Controlling shareholder with sector assets. B&B Media held 61.26%, and it owns or acquired footwear businesses (Socrati, Eddels) that could in principle be injected (FY2023 results).

Weaknesses

  • Chronic losses. Net losses in every audited year from FY2015 to FY2023. Accumulated loss of R111.1m against R113.7m of stated capital (FY2023 results).
  • Equity depletion. NAV per share fell from 303c (FY2019, adjusted) to 7.61c (Aug 2023), roughly a 97% decline.
  • No revenue since February 2022. Revenue was zero in FY2023 and H1 FY2024 (FY2023 results; interim Aug 2023).
  • Cost base dominated by governance costs. Directors' fees were about 53% of FY2023 other operating expenses (R1.016m of R1.921m).
  • Weak historical liquidity. Current ratio of 0.64–0.72x and persistent overdraft in FY2019–FY2020. The auditor flagged material uncertainty on going concern in FY2020 (FY2020 results).
  • Unsuccessful capital raising. The 2018 rights issue raised R3.3m against a R15m target. The planned R7m rights offer in 2020 never happened (BusinessDay 31 Jan 2018; FY2020 and FY2022 results).

Opportunities

  • Reverse takeover of fashion assets. The JSE AltX advisory committee had indicated in 2022 that Buka was eligible to apply for an AltX listing (interim Aug 2022).
  • Vertical integration in footwear. Combining Socrati (retail), Caralli (leather manufacturing) and Eddels (shoe manufacturing) under the B&B Media group (FY2023 results).
  • Assessed tax losses. The accumulated loss is large. Any usable tax losses in the shell (not disclosed) could have value to an acquirer, subject to South African tax anti-avoidance rules.
  • B-BBEE positioning. B&B Media is described as fully Black-owned (interim Aug 2023), which may be attractive in procurement-linked retail and manufacturing.
  • Re-listing or alternative-exchange route. Not disclosed as being pursued.
  • Capital injection by the controlling shareholder. There is a precedent: about R6m was injected in 2022 (FY2022 results).

Threats

  • Delisting already happened. Removed 4 Sep 2024. Minorities have no trading venue and no continuing JSE disclosure obligations (JSE SENS 28 Aug 2024).
  • Possible insolvency. Implied FY2024 year-end equity was close to zero on the trading-statement range (analyst arithmetic from the FY2023 equity of R2.677m).
  • Controlling-shareholder priorities. B&B Media already showed that it would put its own acquisitions (Eddels) ahead of the Buka transaction (FY2023 results).
  • Related-party governance risk. Both the 2022 disposal (to iBloom, with shared directors) and the proposed reverse takeover (from B&B Media) were related-party transactions (Business Report 7 Jul 2021; interim Aug 2023).
  • Regulatory history. Suspension under s3.26 and removal under s12(2) of the Financial Markets Act would complicate any future listing application (FY2023 results; JSE SENS 28 Aug 2024).
  • Information blackout. No disclosures were found after September 2024, so minorities have limited visibility into governance and capital decisions.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
11 Apr 2022SENS circular on consolidation, name change, authorised-capital increase and new directors FY2022 resultsStart of the shell repositioning
25 Apr 2022Four legacy NEDs resign; T Sadik, PAFR Inbona, NVB Magubane, A Bux and A Cassim appointed FY2022 resultsB&B Media consortium takes board control
18 May 2022Shareholders approve the name change to Buka Investments and the 1:100 consolidation FY2022 resultsLegal rebrand
9 Jun 2022FY2022 audited results: R23.4m loss including the R22.4m disposal loss; unmodified opinion FY2022 resultsLast results under the Imbalie name
Jun 2022Press coverage of the renaming (Business Live, 22 Jun 2022, via Team France Export)Market awareness
6 Jul 2022Consolidation effective; share code changes to BKI Profile ShareDataNew ISIN ZAE000309118
14–15 Jul 2022Heads of Agreement for the Socrati/Caralli reverse takeover Interim Aug 2022Proposed requalification route
31 Jul 2022FD A Cassim resigns FY2023 resultsExecutive turnover
1 Aug 2022A Bux appointed CEO; W Grobbelaar appointed FD FY2023 resultsNew management
30 Oct 2022NED NVB Magubane passes away FY2023 resultsBoard vacancy (Social and Ethics chair)
25 Nov 2022Interim results: R0.93m loss; NAV 40.63c; AltX advisory committee supports eligibility; circular deadline 31 Dec 2022 Interim Aug 2022Deal still on track
14 Dec 2022P Tladi appointed independent NED FY2023 resultsBoard strengthened
31 Dec 2022JSE extension deadline for the circular passes without distribution (inferred from the subsequent hold) Interim Aug 2022; FY2023 resultsDeal slippage
Feb 2023B&B Media acquires Eddels Shoes FY2023 resultsControlling shareholder diverts focus
24 Feb 2023Transaction put on hold; JSE suspends Buka under the cash-shell rule (s3.26) FY2023 resultsTrading halted
31 May 2023FY2023 audited results: R3.9m loss; NAV 19.34c; unmodified opinion FY2023 resultsShell erosion visible
29 Sep 2023Interim results: R1.6m loss; NAV 7.61c; revised deal promised within four months Interim Aug 2023Final substantive strategic statement
Jan–Feb 2024Four-month window for the revised transaction lapses without an announcement Inferred from the absence of a SENS announcementStrategy failure
2024 (after suspension)JSE advises Buka it is considering removal under s12(2) of the Financial Markets Act; Buka invited to make written representations JSE SENS 28 Aug 2024Regulatory escalation
27 Jun 2024FY2024 trading statement: loss per share 17.00–20.00c, a 29–39% improvement JSE SENS 27 Jun 2024Lower cost run-rate
Early Jul 2024 (expected)FY2024 results due "first week of July 2024" JSE SENS 27 Jun 2024–
28 Aug 2024JSE announces the decision to remove the listing; issuer does not appeal JSE SENS 28 Aug 2024Effective end of the listed life
3 Sep 2024Record date; final market capitalisation R10.1m JSE SENS; Profile ShareData—
4 Sep 2024Listing removed; shareholders hold unlisted shares JSE SENS 28 Aug 2024; Profile Stock Exchange Handbook 2024 Issue 4Delisting
Sep 2024 – Oct 2026Information blackout for minority holders

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Revenue incl. discontinued operations fell from ZAR 41.8 Mn in FY2019 to ZAR 0 Mn in FY2023.
Buka Investments Limited — Income Statement: Revenue & Gross Profit
Series (ZAR Mn)FY2019FY2020FY2021FY2022FY2023
Revenue incl. discontinued operations41.833.619190
Cost of sales16.110.25.55.40
Gross profit25.723.413.613.60

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. JSE SENS, Buka Investments, "Removal of Listing Announcement", 28 Aug 2024 · sharedata.co.za
  2. JSE SENS, Buka Investments, "Trading Update", FY2024, 27 Jun 2024 (senspdf.jse.co.za)
  3. Buka Investments, unaudited interim results to 31 Aug 2023 (senspdf.jse.co.za)
  4. Buka Investments, audited results FY2023 (year to 28 Feb 2023) (senspdf.jse.co.za)
  5. Buka Investments, unaudited interim results to 31 Aug 2022 (senspdf.jse.co.za)
  6. Imbalie Beauty, audited results FY2022 (year to 28 Feb 2022) (senspdf.jse.co.za)
  7. Imbalie Beauty, reviewed provisional results FY2020 (year to 29 Feb 2020) (senspdf.jse.co.za)
  8. Imbalie Beauty, interim results to 31 Aug 2020 (senspdf.jse.co.za)
  9. Imbalie Beauty, interim results to 31 Aug 2019 (senspdf.jse.co.za)
  10. Imbalie Beauty, FY2016 provisional results (SENS 31 May 2016) (sharedata.co.za)
  11. Imbalie Beauty, Cavi Brands conditional offer (SENS 7 Jul 2017) (sharedata.co.za)
  12. Skinwell Holdings, Perfect 10 acquisition and name change (SENS 6 Mar 2012) (sharedata.co.za)
  13. Profile ShareData, Buka Investments fact sheet and news · sharedata.co.za · sharedata.co.za
  14. Profile's Stock Exchange Handbook 2024 Issue 4, delistings list (sharedata.co.za)
  15. Profile's Stock Exchange Handbook 2021 (Imbalie Beauty entry) (profile.co.za)
  16. Business Report / IOL, "Imbalie Beauty enters agreement to sell its subsidiaries to iBloom", 7 Jul 2021 (iol.co.za)
  17. BusinessDay, "Imbalie Beauty's makeover takes a toll", 2 Jun 2017 (businesslive.co.za)
  18. BusinessDay, "Rights issue to aid Imbalie liquidity", 31 Jan 2018 (businessday.co.za)
  19. Ghost Mail, "Vuka, Buka" (ghostmail.co.za)
  20. Team France Export, Imbalie Beauty becomes i-Bloom (citing Professional Beauty, 31 Jan 2022) (teamfrance-export.fr)
  21. Team France Export, Imbalie Beauty name change (citing Business Live, 22 Jun 2022) (teamfrance-export.fr)
  22. Yahoo Finance, BKI.JO profile (nz.finance.yahoo.com)
  23. Investing.com, company profile (board list) (m.uk.investing.com)
  24. Simply Wall St, JSE:BKI (simplywall.st)
  25. GuruFocus, JSE:BKI summary (test.gurufocus.com)
  26. iocharts, BKI.JSE (aggregator returns) (preview.iocharts.io)
  27. TradingView commentary on BKI (tr.tradingview.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.